HUMANA INC (HUM)
Every FINRA and SEC series the site collects for HUMANA INC: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on NYSE, classified by the SEC as hospital & medical service plans.
3.4M
Short interest
settlement 2026-08-14
2.8
Days to cover
-8.1% vs prior
52.7%
Short share of volume
2026-09-11
1,000
Fails to deliver
settlement 2026-08-10
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-09-11.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 14 August 2026, short interest in HUM is 3,361,629 shares, down 890,193 shares over the last month. Over the last 48 readings it ranged from 2,114,247 shares (30 August 2024) to 6,323,340 shares (15 June 2026). At the reported average volume of 1.2M shares a day that is 2.8 days to cover.
Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/hum" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-14 | 3,361,629 | -8.1% | 1,187,513 | 2.83 |
| 2026-07-31 | 3,659,421 | -13.9% | 1,689,672 | 2.17 |
| 2026-07-15 | 4,251,822 | -1.8% | 1,315,609 | 3.23 |
| 2026-06-30 | 4,327,430 | -31.6% | 1,726,267 | 2.51 |
| 2026-06-15 | 6,323,340 | +3.4% | 1,364,426 | 4.63 |
| 2026-05-29 | 6,117,059 | +2.1% | 1,139,058 | 5.37 |
| 2026-05-15 | 5,989,905 | -4.5% | 2,008,266 | 2.98 |
| 2026-04-30 | 6,275,283 | +15.7% | 2,060,260 | 3.05 |
| 2026-04-15 | 5,422,616 | -8.7% | 1,848,828 | 2.93 |
| 2026-03-31 | 5,937,118 | +19.3% | 1,708,634 | 3.47 |
| 2026-03-13 | 4,977,893 | -1.3% | 1,492,599 | 3.34 |
| 2026-02-27 | 5,043,434 | -3.1% | 1,789,843 | 2.82 |
| 2026-02-13 | 5,207,601 | -11.0% | 3,093,176 | 1.68 |
| 2026-01-30 | 5,853,871 | -4.1% | 3,298,581 | 1.77 |
| 2026-01-15 | 6,106,941 | +15.3% | 885,013 | 6.90 |
| 2025-12-31 | 5,295,934 | +9.9% | 1,120,112 | 4.73 |
| 2025-12-15 | 4,819,305 | +0.7% | 1,630,675 | 2.96 |
| 2025-11-28 | 4,784,843 | +12.8% | 1,591,041 | 3.01 |
| 2025-11-14 | 4,243,688 | +9.5% | 1,842,566 | 2.30 |
| 2025-10-31 | 3,876,253 | -2.4% | 1,379,937 | 2.81 |
| 2025-10-15 | 3,972,444 | +20.4% | 2,463,164 | 1.61 |
| 2025-09-30 | 3,299,575 | -19.1% | 1,982,258 | 1.66 |
| 2025-09-15 | 4,078,437 | -11.8% | 2,161,256 | 1.89 |
| 2025-08-29 | 4,625,645 | -12.2% | 1,203,994 | 3.84 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 11 September 2026, the short share of HUM volume is 52.7%, up 2.9 points over the last five sessions. Over the last 52 readings it ranged from 22.7% (6 July 2026) to 69.1% (13 August 2026). The latest reading is in line with the 30-session average of 52.0%, on 276K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-11 | 146K | 276K | 52.7% | 0 |
| 2026-09-10 | 130K | 289K | 45.1% | 0 |
| 2026-09-09 | 233K | 373K | 62.6% | 0 |
| 2026-09-08 | 152K | 229K | 66.5% | 5 |
| 2026-09-04 | 135K | 301K | 44.9% | 3 |
| 2026-09-03 | 167K | 335K | 49.8% | 0 |
| 2026-09-02 | 282K | 521K | 54.1% | 0 |
| 2026-09-01 | 245K | 439K | 55.9% | 7,159 |
| 2026-08-31 | 114K | 211K | 53.8% | 10 |
| 2026-08-28 | 166K | 263K | 63.1% | 0 |
| 2026-08-27 | 219K | 415K | 52.9% | 200 |
| 2026-08-26 | 222K | 389K | 57.1% | 8 |
| 2026-08-25 | 229K | 469K | 48.9% | 0 |
| 2026-08-24 | 185K | 610K | 30.3% | 4,717 |
| 2026-08-21 | 204K | 372K | 54.7% | 0 |
| 2026-08-20 | 314K | 614K | 51.1% | 102 |
| 2026-08-19 | 165K | 523K | 31.6% | 2 |
| 2026-08-18 | 120K | 226K | 53.2% | 0 |
| 2026-08-17 | 135K | 260K | 52.1% | 1 |
| 2026-08-14 | 196K | 303K | 64.5% | 0 |
| 2026-08-13 | 211K | 306K | 69.1% | 0 |
| 2026-08-12 | 344K | 550K | 62.5% | 300 |
| 2026-08-11 | 196K | 306K | 63.9% | 26 |
| 2026-08-10 | 186K | 381K | 48.8% | 0 |
| 2026-08-07 | 238K | 507K | 47.0% | 135 |
| 2026-08-06 | 265K | 545K | 48.6% | 18 |
| 2026-08-05 | 220K | 503K | 43.7% | 106 |
| 2026-08-04 | 235K | 534K | 44.0% | 0 |
| 2026-08-03 | 262K | 544K | 48.1% | 15 |
| 2026-07-31 | 210K | 532K | 39.4% | 134 |
Fails to deliver
SEC, by settlement date. JSONAs of 10 August 2026, the fails-to-deliver balance in HUM is 1,000 shares, up 999 shares over the last settlement date. Over the last 47 readings it ranged from 1 share (3 December 2025) to 44,156 shares (22 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-10 | 1,000 | $385.00 | $385K |
| 2026-07-30 | 1 | $365.41 | $365 |
| 2026-07-10 | 13 | $397.76 | $5K |
| 2026-07-09 | 4,596 | $396.29 | $1.8M |
| 2026-07-06 | 12 | $396.75 | $5K |
| 2026-06-30 | 18 | $388.90 | $7K |
| 2026-06-25 | 280 | $361.64 | $101K |
| 2026-06-22 | 44,156 | $360.65 | $15.9M |
| 2026-06-15 | 2,200 | $379.22 | $834K |
| 2026-06-12 | 322 | $368.69 | $119K |
| 2026-06-08 | 1,000 | $350.08 | $350K |
| 2026-06-02 | 30 | $328.31 | $10K |
| 2026-06-01 | 5,100 | $305.42 | $1.6M |
| 2026-04-30 | 21,273 | $243.12 | $5.2M |
| 2026-04-28 | 125 | $223.62 | $28K |
| 2026-04-23 | 2,615 | $217.40 | $569K |
| 2026-04-20 | 514 | $205.14 | $105K |
| 2026-04-10 | 554 | $197.32 | $109K |
| 2026-04-09 | 30,591 | $198.39 | $6.1M |
| 2026-04-08 | 31,848 | $197.15 | $6.3M |
| 2026-03-27 | 49 | $175.14 | $9K |
| 2026-03-26 | 6,115 | $174.24 | $1.1M |
| 2026-03-25 | 12 | $172.23 | $2K |
| 2026-03-23 | 69 | $169.90 | $12K |
| 2026-03-06 | 117 | $180.75 | $21K |
| 2026-03-05 | 117 | $183.11 | $21K |
| 2026-02-23 | 136 | $189.83 | $26K |
| 2026-02-19 | 1,558 | $187.12 | $292K |
| 2026-02-17 | 28,251 | $184.10 | $5.2M |
| 2026-02-11 | 839 | $181.30 | $152K |
Insider trades
SEC Form 4, newest first, 50 of 66 shown. JSONNo open-market insider trades were reported for HUM in the last 90 days. The most recent filings are listed below; grants and option exercises carry a weaker signal than voluntary trades. Latest filing: Nundy Shantanu (Chief Medical Officer) on 2026-09-01.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Nundy Shantanu | Chief Medical Officer | Grant | 3K | $0.00 | $0 | 3K |
| 2026-08-01 | Smith Paul John | n/a | Grant | 544 | $0.00 | $0 | 544 |
| 2026-08-01 | Crawford Frederick John | n/a | Grant | 544 | $0.00 | $0 | 544 |
| 2026-05-01 | Martin Aaron | President, Medicare Advantage | Grant | 8K | $0.00 | $0 | 25K |
| 2026-05-01 | Mehta Japan | Chief Information Officer | Grant | 9K | $0.00 | $0 | 17K |
| 2026-05-01 | Rechtin James A. | President & CEO | Grant | 36K | $0.00 | $0 | 64K |
| 2026-05-01 | Shetty Sanjay K | President, CenterWell | Grant | 10K | $0.00 | $0 | 22K |
| 2026-05-01 | O'Hara Michelle A. | Chief Human Resources Officer | Grant | 10K | $0.00 | $0 | 20K |
| 2026-05-01 | Ventura Joseph C | Chief Legal Officer | Grant | 10K | $0.00 | $0 | 27K |
| 2026-05-01 | Mellet Celeste | Chief Financial Officer | Grant | 15K | $0.00 | $0 | 40K |
| 2026-05-01 | Field Robert Stuart | n/a | Grant | 852 | $0.00 | $0 | 852 |
| 2026-05-01 | Dintenfass David | President, Enterprise Growth | Grant | 11K | $0.00 | $0 | 25K |
| 2026-04-01 | Shetty Sanjay K | President, CenterWell | Tax withholding | 401 | $175.44 | $70K | 12K |
| 2026-04-01 | Shetty Sanjay K | President, CenterWell | Option exercise | 887 | $0.00 | $0 | 13K |
| 2026-02-24 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Tax withholding | 84 | $177.07 | $15K | 7K |
| 2026-02-24 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Option exercise | 165 | $0.00 | $0 | 8K |
| 2026-02-24 | Renaudin George II | President, Insurance | Tax withholding | 419 | $177.07 | $74K | 16K |
| 2026-02-24 | Renaudin George II | President, Insurance | Option exercise | 1K | $0.00 | $0 | 16K |
| 2026-02-24 | Ventura Joseph C | Chief Legal Officer | Tax withholding | 478 | $177.07 | $85K | 17K |
| 2026-02-24 | Ventura Joseph C | Chief Legal Officer | Option exercise | 1K | $0.00 | $0 | 18K |
| 2026-02-23 | Shetty Sanjay K | President, CenterWell | Buy | 810 | $185.21 | $150K | 12K |
| 2026-02-23 | Felter John-Paul W. | SVP, Chief Accting Off & Cont. | Grant | 6K | $0.00 | $0 | 7K |
| 2026-02-21 | Dintenfass David | President, Enterprise Growth | Tax withholding | 1K | $189.66 | $224K | 14K |
| 2026-02-21 | Dintenfass David | President, Enterprise Growth | Option exercise | 4K | $0.00 | $0 | 15K |
| 2026-02-13 | Mehta Japan | Chief Information Officer | Tax withholding | 430 | $181.46 | $78K | 8K |
| 2026-02-13 | Mehta Japan | Chief Information Officer | Option exercise | 2K | $0.00 | $0 | 8K |
| 2026-02-13 | Mellet Celeste | Chief Financial Officer | Tax withholding | 4K | $181.46 | $763K | 24K |
| 2026-02-13 | Mellet Celeste | Chief Financial Officer | Option exercise | 8K | $0.00 | $0 | 28K |
| 2026-02-12 | Martin Aaron | President, Medicare Advantage | Grant | 17K | $0.00 | $0 | 17K |
| 2026-01-08 | Rechtin James A. | President & CEO | Tax withholding | 980 | $279.15 | $274K | 28K |
| 2026-01-08 | Rechtin James A. | President & CEO | Option exercise | 2K | $0.00 | $0 | 29K |
| 2026-01-02 | Mesquita Jorge S. | n/a | Grant | 766 | $0.00 | $0 | 4K |
| 2026-01-02 | Feinberg David T | n/a | Grant | 766 | $0.00 | $0 | 1K |
| 2026-01-01 | O'Hara Michelle A. | Chief Human Resources Officer | Tax withholding | 1K | $258.87 | $283K | 10K |
| 2026-01-01 | O'Hara Michelle A. | Chief Human Resources Officer | Option exercise | 2K | $0.00 | $0 | 11K |
| 2025-12-15 | Mehta Japan | Chief Information Officer | Tax withholding | 470 | $270.15 | $127K | 8K |
| 2025-12-15 | Mehta Japan | Chief Information Officer | Option exercise | 1K | $0.00 | $0 | 9K |
| 2025-12-15 | Rechtin James A. | President & CEO | Tax withholding | 3K | $270.15 | $911K | 27K |
| 2025-12-15 | Rechtin James A. | President & CEO | Option exercise | 8K | $0.00 | $0 | 30K |
| 2025-12-15 | Shetty Sanjay K | President, CenterWell | Tax withholding | 139 | $270.15 | $38K | 11K |
| 2025-12-15 | Shetty Sanjay K | President, CenterWell | Option exercise | 308 | $0.00 | $0 | 11K |
| 2025-12-15 | Shetty Sanjay K | President, CenterWell | Tax withholding | 888 | $270.15 | $240K | 11K |
| 2025-12-15 | Shetty Sanjay K | President, CenterWell | Option exercise | 2K | $0.00 | $0 | 12K |
| 2025-12-15 | Renaudin George II | President, Insurance | Tax withholding | 142 | $270.15 | $38K | 15K |
| 2025-12-15 | Renaudin George II | President, Insurance | Option exercise | 360 | $0.00 | $0 | 16K |
| 2025-12-15 | Renaudin George II | President, Insurance | Tax withholding | 830 | $270.15 | $224K | 15K |
| 2025-12-15 | Renaudin George II | President, Insurance | Option exercise | 2K | $0.00 | $0 | 16K |
| 2025-12-15 | O'Hara Michelle A. | Chief Human Resources Officer | Tax withholding | 632 | $270.15 | $171K | 11K |
| 2025-12-15 | O'Hara Michelle A. | Chief Human Resources Officer | Option exercise | 1K | $0.00 | $0 | 11K |
| 2025-12-15 | Ventura Joseph C | Chief Legal Officer | Tax withholding | 164 | $270.15 | $44K | 17K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
13F holders
Tracked managers holding HUM at their latest 13F. JSON10 of the 30 tracked managers held HUM at their latest 13F, $1.34B in total at quarter-end prices. Citadel Advisors is the largest at $852.6M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 5 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 2.1M | $852.6M | 0.10% | +343K |
| Millennium Management | 2026-06-30 | 467K | $185.7M | 0.07% | -262K |
| D. E. Shaw & Co. | 2026-06-30 | 359K | $142.5M | 0.07% | -319K |
| AQR Capital Management | 2026-06-30 | 222K | $86.8M | 0.03% | +30K |
| Point72 Asset Management | 2026-06-30 | 128K | $50.8M | 0.06% | +73K |
| Soros Fund Management | 2026-06-30 | 33K | $13.2M | 0.16% | -34K |
| Bridgewater Associates | 2026-06-30 | 9K | $3.6M | 0.01% | +3K |
| Renaissance Technologies | 2026-06-30 | 9K | $3.4M | 0.00% | -1K |
| Two Sigma Investments | 2026-06-30 | 5K | $2.1M | 0.00% | -53K |
| Fisher Asset Management | 2026-06-30 | 843 | $335K | 0.00% | +25 |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q1 2026 (quarter ended 2026-03-31) HUMANA INC reported revenue of $39.65B, up 23.5% from the same quarter a year earlier, and net income of $1.19B (9.83 diluted EPS). In FY 2025 it generated $921.0M of operating cash flow and spent $151.0M on buybacks and $430.0M on dividends. As of 2026-03-31, cash was $4.95B against $13.99B of debt.
- Cash
- $4.95B
- Debt
- $13.99B
- Equity
- $18.58B
- Total assets
- $55.28B
- Shares outstanding
- 120,061,500
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $39.65B | $1.19B | 3.0% | 9.83 |
| Q4 2025derived | 2025-12-31 | $32.52B | -$796.0M | -2.4% | n/a |
| Q3 2025 | 2025-09-30 | $32.65B | $195.0M | 0.6% | 1.62 |
| Q2 2025 | 2025-06-30 | $32.39B | $545.0M | 1.7% | 4.51 |
| Q1 2025 | 2025-03-31 | $32.11B | $1.24B | 3.9% | 10.30 |
| Q4 2024derived | 2024-12-31 | $29.21B | -$693.0M | -2.4% | n/a |
| Q3 2024 | 2024-09-30 | $29.40B | $480.0M | 1.6% | 3.98 |
| Q2 2024 | 2024-06-30 | $29.54B | $679.0M | 2.3% | 5.62 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $129.66B | $1.19B | $921.0M | $546.0M | $151.0M | $430.0M |
| FY 2024 | 2024-12-31 | $117.76B | $1.21B | $2.97B | $575.0M | $817.0M | $431.0M |
| FY 2023 | 2023-12-31 | $106.37B | $2.49B | $3.98B | $1.00B | $1.57B | $431.0M |
| FY 2022 | 2022-12-31 | $92.87B | $2.81B | $4.59B | $1.14B | $2.10B | $98.0M |
| FY 2021 | 2021-12-31 | $83.06B | $2.93B | $2.26B | $1.34B | $79.0M | $90.0M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-03-31; shares outstanding as of 2026-03-31 from the cover page.
What this page is
HUMANA INC in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows HUMANA INC (HUM), SEC CIK 49071, listed on NYSE, classified by the SEC as hospital & medical service plans. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-10.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-03-31.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-01.JSON and CSV
- Company record
- EDGAR filing index for CIK 49071Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 09:50 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as hospital & medical service plans
- UNHUNITEDHEALTH GROUP INC
- ALHCAlignment Healthcare, Inc.
- CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
- CICigna Group
- ELVElevance Health, Inc.
- MOHMOLINA HEALTHCARE, INC.
- CRWVCoreWeave, Inc.
- UTHRUNITED THERAPEUTICS Corp
- TEAMAtlassian Corp
- CVNACARVANA CO.
- CRWDCrowdStrike Holdings, Inc.
- RCGRENN Fund, Inc.
- APPAppLovin Corp
- SESea Ltd
- VICRVICOR CORP
- GOOGLAlphabet Inc.
- ANETArista Networks, Inc.
- CRMSalesforce, Inc.
- RDDTReddit, Inc.
- CRDOCredo Technology Group Holding Ltd
- NVDANVIDIA CORP
- METAMeta Platforms, Inc.
- STXSeagate Technology Holdings plc
- APPFAPPFOLIO INC
Datasets
Frequently Asked Questions
How much of HUM is sold short?
What is HUM's daily short volume?
Does HUM have fails to deliver?
Are HUM insiders buying or selling?
What did HUM report last quarter?
Which funds hold HUM?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.